Data / Drug companies / Latanoprost
Latanoprost: 15 companies and 17 products in the FDA NDC directory
Latanoprost is listed in the FDA National Drug Code Directory by 15 companies, with 17 products in commercial distribution. 14 of the products (82.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution/ drops; solution, and the newest product started marketing on January 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 15
- Products
- 17
- Generic (ANDA) products
- 14 (82.4%)
- Application numbers
- 9
- Routes
- Ophthalmic, Topical
- Brand names
- Xalatan, Xelpros
- openFDA record search
- api.fda.gov
Companies that list latanoprost
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 2 | solution/ drops; solution | Generic drugs (ANDA) | March 22, 2011 |
| NuCare Pharmaceuticals,Inc. | 2 | solution/ drops; solution | Generic drugs (ANDA) | December 3, 2019 |
| Aurobindo Pharma Limited | 1 | solution/ drops | Generic drugs (ANDA) | September 3, 2019 |
| Bausch & Lomb Incorporated | 1 | solution/ drops | Generic drugs (ANDA) | March 22, 2011 |
| Gland Pharma Limited | 1 | solution/ drops | Generic drugs (ANDA) | November 26, 2024 |
| Glenmark Pharmaceuticals Inc., USA | 1 | solution/ drops | Generic drugs (ANDA) | November 26, 2024 |
| Micro Labs Limited | 1 | solution/ drops | Generic drugs (ANDA) | January 22, 2026 |
| Mylan Pharmaceuticals Inc. | 1 | solution | Authorized generics (NDA) | November 15, 2010 |
| Proficient Rx LP | 1 | solution/ drops | Generic drugs (ANDA) | March 22, 2011 |
| Rising Pharma Holdings, Inc. | 1 | solution | Generic drugs (ANDA) | September 1, 2016 |
| Sagent Pharmaceuticals | 1 | solution/ drops | Generic drugs (ANDA) | July 15, 2025 |
| Sandoz Inc | 1 | solution | Generic drugs (ANDA) | January 7, 2011 |
| Somerset Therapeutics, LLC | 1 | solution/ drops | Generic drugs (ANDA) | December 3, 2019 |
| Sun Pharmaceutical Industries, Inc. | 1 | solution/ drops | New drug applications (NDA) | September 12, 2018 |
| Viatris Specialty LLC | 1 | solution/ drops | New drug applications (NDA) | October 22, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution/ drops | 12 | 70.6% |
| Solution | 5 | 29.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 14 | 82.4% |
| New drug applications (NDA) | 2 | 11.8% |
| Authorized generics (NDA) | 1 | 5.9% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.